Non-neoplastic and neoplastic pleural endpoints following fiber exposure

Journal of Toxicology and Environmental Health - Part B: Critical Reviews

Volumn 14, Issue 1-4, 2011, Pages 153-178

  Broaddus, V Courtney ^a   Everitt, Jeffrey I ^b   Black, Brad ^c   Kane, Agnes B ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b GLAXOSMITHKLINE   (United States)

^c Center for Asbestos Related Disease   (United States)

^d BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASBESTOS FIBER; NANOTUBE;

CELL INTERACTION; DOSIMETRY; GENE TRANSLOCATION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MESOTHELIUM CELL; NONHUMAN; PHYSICAL CHEMISTRY; PLEURA CANCER; PLEURA DISEASE; REVIEW; TARGET CELL; TOXICITY;

ANIMALS; ASBESTOS; BIOLOGICAL TRANSPORT; CARCINOGENS, ENVIRONMENTAL; ENVIRONMENTAL POLLUTANTS; HUMANS; MINERAL FIBERS; PLEURAL DISEASES; PLEURAL NEOPLASMS;

EID: 79959218679     PISSN: 10937404     EISSN: 15216950     Source Type: Journal    
DOI: 10.1080/10937404.2011.556049     Document Type: Review

References (155)

1. Adamson, I. Y. 1997. Early mesothelial cell proliferation after asbestos exposure: in vivo and in vitro studies. Environ. Health Perspect. 105:1205-1208.
2. Albrecht, C., Borm, P. J., and Unfried, K. 2004. Signal transduction pathways relevant for neoplastic effects of fibrous and non-fibrous particles. Mutat Res 553: 23-35. (Pubitemid 38993720)
3. Altomare, D. A., You, H., Xiao, G. H., Ramos-Nino, M. E., Skele, K. L., De Rienzo, A., Jhanwar, S. C., Mossman, B. T., Kane, A. B., and Testa, J. R. 2005. Human and mouse mesotheliomas exhibit elevated AKT/PKB activity, which can be targeted pharmacologically to inhibit tumor cell growth. Oncogene 24:6080-6089.
4. American Thoracic Society. (ATS) 2004. Diagnosis and initial management of non-malignant diseases related to asbestos. Am. J. Respir. Crit. Care Med. 170:691-715.
5. Andujar, P., Lecomte, C., Renier, A., Fleury-Feith, J., Kheuang, L., Daubriac, J., Janin, A., and Jaurand, M. C. 2007. Clinico-pathological features and somatic gene alterations in refractory ceramic fibre-induced murine mesothelioma reveal mineral fibre-induced mesothelioma identities. Carcinogenesis 28:1599-1605.
6. Apostolou, S., Balsara, B. R., and Testa, J. R. 2005. Cytogenetics of malignant mesothelioma. Malignant mesothelioma. In Advances in pathogenesis, diagnosis and translational therapies, eds. H. I. Pass, N. J. Vogelzang, and M. Carbone, vol, 6, pp. 101-111. New York: Springer Science and Business Media.
7. Aust, A. E., Cook, P. M., and Dodson, R. F. 2011. Morphological and chemical mechanisms of elongated mineral particle toxicities. J. Toxicol. Environ. Health B, 14:40-75.
8. Barbone, D., Yang, T. M., Morgan, J. R., Gaudino, G., and Broaddus, V. C. 2008. Mammalian target of rapamycin contributes to the acquired apoptotic resistance of human mesothelioma multicellular spheroids. J. Biol. Chem. 283:13021-13030.
9. Baumann, M. H., Heinrich, K., Sahn, S. A., and Strange, C. 1993. Pleural macrophages differentially alter mesothelial cell growth and collagen production. Inflammation 17:1-12. (Pubitemid 23023968)
10. Baumann, M. H., Strange, C., Sahn, S. A., and Kinasewitz, G. T. 1996. Pleural macrophages differentially alter pleural mesothelial cell glycosaminoglycan production. Exp. Lung Res. 22:101-111.
11. Berman, D. W., and Crump, K. S. 2008. A meta-analysis of asbestos-related cancer risk that addresses fiber size and mineral type. Crit. Rev. Toxicol. 38:49-73.
12. Berman, D. W., Crump, K. S., Chatfield, E. J., Davis, J. M., and Jones, A. D. 1995. The sizes, shapes, and mineralogy of asbestos structures that induce lung tumors or mesothelioma in AF/HAN rats following inhalation. Risk Anal. 15:181-195.
13. Bermudez, E., Mangum, J. B., Asgharian, B., Wong, B. A., Reverdy, E. E., Janszen, D. B., Hext, P. M., Warheit, D. B., and Everitt, J. I. 2002. Long-term pulmonary responses of three laboratory rodent species to sub-chronic inhalation of pigmentary titanium dioxide particles. Toxicol. Sci. 70:86-97. (Pubitemid 35331794)
14. Bernstein, D. M. 2007. Synthetic vitreous fibers: A review toxicology, epidemiology and regulations. Crit. Rev. Toxicol. 37: 839-886. (Pubitemid 350139219)
15. Bernstein, D. M., Chevalier, J., and Smith, P. 2005. Comparison of Calidria chrysotile asbestos to pure tremolite: Final results of the inhalation biopersistence and histopathology examination following short-term exposure. Inhal. Toxicol. 17:427-449. (Pubitemid 40875320)
16. Bernstein, D. M., Donaldson, K., Decker, U., Gaering, S., Kunzendorf, P., Chevalier, J., and Holm, S. E. 2008. A biopersistence study following exposure to chrysotile asbestos alone or in combination with fine particles. Inhal. Toxicol. 20:1009-1028.
17. Bernstein, D. M., and Hoskins, J. A. 2006. The health effects of chrysotile: current perspective based upon recent data. Regul. Toxicol. Pharmacol. 45:252-264.
18. Bernstein, D. M., Riego Sintes, J. M., Ersboell, B. K., and Kunert, J. 2001. Biopersistence of synthetic mineral fibers as a predictor of chronic inhalation toxicity in rats. Inhal. Toxicol. 13:823-849. (Pubitemid 33020392)
19. Bernstein, D. M., Thevenaz, P., Fleissner, H., Anderson, R., Hesterberg, T. W., and Mast, R. 1995. Evaluation of the oncogenic potential of man-made vitreous fibres: The inhalation model. Ann. Occup. Hyg. 39:661-672.
20. BéruBé, K. A., Quinlan, T. R., Fung, H., Magae, J., Vacek, P., Taatjes, D. J., and Mossman, B. T. 1996. Apoptosis is observed in mesothelial cells after exposure to crocidolite asbestos. Am. J. Respir. Cell Mol. Biol. 15:141-147.
21. Boutin, C., Dumortier, P., Rey, F., Viallat, J. R., and DeVuyst, P. 1996. Black spots concentrate oncogenic asbestos fibers in the parietal pleura: Thoracoscopic and mineralogic study. Am. J. Respir. Crit. Care Med. 153:444-449. (Pubitemid 26026887)
22. Boutin, C., and Rey, F. 1993. Thoracoscopy in pleural malignant mesothelioma: A prospective study of 188 consecutive patients: Part I. Diagnosis. Cancer 72:389-393. (Pubitemid 23193443)
23. Boutin, C., Schlesser, M., Frenay, G., and Germain, S. 1997. Malignant mesothelioma. Diagnosis and treatment. Rev. Pract. 47:1333-1339.
24. Boylan, A. M., Ruegg, C., Kim, K. J., Hebert, C. A., Hoeffel, J. M., Pytela, R., Sheppard, D., Goldstein, I. M., and Broaddus, V. C. 1992. Evidence of a role for mesothelial cell-derived interleukin-8 in the pathogenesis of asbestos-induced pleurisy in rabbits. J. Clin. Invest. 89:1257-1267.
25. Boylan, A. M., Sanan, D. A., Sheppard, D., and Broaddus, V. C. 1995. Vitronectin enhances internalization of crocidolite asbestos by rabbit pleural mesothelial cells via the integrin alpha v beta 5. J. Clin. Invest. 96:1987-2001.
26. Broaddus, V. C. 1997. Asbestos, the mesothelial cell and malignancy: A matter of life or death. Am. J. Respir. Cell Mol. Biol. 17: 657-659.
27. Broaddus, V. C. 2002. Transudative pleural effusions. In Pleural diseases, European Respiratory Monograph 22, eds. R. Loddenkemper and V. Anthony, pp. 157-176. Sheffield, UK: European Respiratory Society Journals
28. Broaddus, V. C. 2008. Physiology: fluid and solute exchange in normal physiological states. In Textbook of pleural diseases, eds. R. Light and Y. Lee, pp. 43-48. London: Hodder Arnold.
29. Broaddus, V. C., Wiener-Kronish, J. P., Berthiaume, Y., and Staub, N. C. 1988. Removal of pleural liquid and protein by lymphatics in awake sheep. J. Appl. Physiol. 64:384-390.
30. Broaddus, V. C., Wiener-Kronish, J. P., and Staub, N. C. 1990. Clearance of lung edema into the pleural space of volume-loaded, anesthetized sheep. J. Appl. Physiol. 68:2623-2630.
31. Broaddus, V. C., Yang, L., Scavo, L. M., Ernest, J. D., and Boylan, A. M. 1996. Asbestos induces apoptosis of human and rabbit pleural mesothelial cells via reactive oxygen species. J. Clin. Invest. 98:2050-2059.
32. Case, B. W., Abraham, J., Meeker, G., Pooley, F. D., and Pinkerton, K. E. 2011. Applying definitions of "asbestos" to environmental and "low-dose" exposure levels and health effects, particularly malignant mesothelioma. J. Toxicol. Environ. Health B. 14: 3-39.
33. Cassel, S. L., Eisenbarth, S. C., Iyer, S. S., Sadler, J. J., Colegio, O. R., Tephly, L. A., Carter, A. B., Rotham, P. B., Flavell, R. A., and Sutterwala, F. S. 2008. The Nalp3 inflammasome is essential for the development of silicosis. Proc. Natl. Acad. Sci. USA 105:9035-9040.
34. Chapman, S. J., Cookson, W. O. C., Musk, A. W., and Lee, Y. C. 2003. Benign asbestos pleural diseases. Curr. Opin. Pulm. Med. 9:266-271.
35. Choe, N., Tanaka, S., Xia, W., Hemenway, D. R., Roggli, V. L., and Kagan, E. 1997. Pleural macrophage recruitment and activation in asbestos-induced pleural injury. Environ. Health Perspect. 105:1257-1260.
36. Christensen, B. C., Marsit, C. J., Houseman, E. A., Godleski, J. J., Longacker, J. L., Zheng, S., Yeh, R. F., Wrensch, M. R., Wiemels, J. L., Karagas, M. R., Bueno, R., Sugarbaker, D. J., Nelson, H. H., Wiencke, J. K., and Kelsey, K. T. 2009. Differentiation of lung adenocarcinoma, pleural mesothelioma, and nonmalignant pulmonary tissues using DNA methylation profiles. Cancer Res. 69:6315-6321.
37. Churg, A. 1982. Asbestos fibers and pleural plaques in a general autopsy population. Am. J. Pathol. 109:88-96. (Pubitemid 12003001)
38. Churg, A. 1983. Current issues in the pathologic and mineralogic diagnosis of asbestos-induced disease. Chest 84:275-280. (Pubitemid 13005394)
39. Churg, A. 1994. Deposition and clearance of chrysotile asbestos. Ann. Occup. Hyg. 38:625-633. (Pubitemid 24274617)
40. Churg, A., and Warnock, M. L. 1980. Asbestos fibers in the general population. Am. Rev. Respir. Dis. 122:669-678.
41. Daubriac, J., Fleury-Feith, J., Kheuang, L., Galipon, J., Saint-Albin, A., Renier, A., Giovannini, M., Galateau-Sallé, F., and Jaurand, M. C. 2009. Malignant pleural mesothelioma cells resist anoikis as quiescent pluricellular aggregates. Cell Death Differ. 16:1146-1155.
42. Davis, J. M. G. 1974. An electron microscope study of the response of mesothelial cells to the intrapleural injection of asbestos dust. Br. J. Exp. Pathol. 55:64-70.
43. Davis, J. M., Jones, A. D., and Miller, B. G. 1991. Experimental studies in rats on the effects of asbestos inhalation coupled with the inhalation of titanium dioxide or quartz. Int. J. Exp. Pathol. 72:501-525.
44. Decologne, N., Kolb, M., Margetts, P. J., Menetrier, F., Artur, Y., Garrido, C., Gauldie, J., Camus, P., and Bonniaud, P. 2007. TGF-beta1 induces progressive pleural scarring and subpleural fibrosis. J. Immunol. 179:6043-6051.
45. DeVuyst, P., Karjalainen, A., Dumortier, P., Pairon, J., Monso, E., Brochard, P., Teschlet, H., Tossavainen, A., and Gibbs, A. 1998. Guidelines for mineral fibre analyses in biological samples: Report of the ERS Working Group. Eur. Respir. J. 11:1416-1426. (Pubitemid 28298611)
46. Dodson, R. F., and Atkinson, M. A. L. 2006. Measurements of asbestos burden in tissues. Ann. NY Acad. Sci. 1076:281-291.
47. Dodson, R. F., and Hammar, S. P. 2006. Pleural mesothelioma in a woman whose documented past exposure to asbestos was from smoking asbestos-containing filtered cigarettes: The comparative value of analytical transmission electron microscopic analysis of lung and lymph node tissue. Inhal. Toxicol. 18:679-684.
48. Dodson, R. F., Atkinson, M. A., and Levin, J. L. 2003. Asbestos fiber length as related to potential pathogenicity: a critical review. Am. J. Ind. Med. 44:291-297.
49. Dodson, R. F., Graef, R., Shepherd, S., O'Sullivan, M., and Levin, J. 2005. Asbestos burden in cases of mesothelioma from individuals from various regions of the United States. Ultrastruct. Pathol. 29: 415-433. (Pubitemid 41577221)
50. Dodson, R. F., Shepherd, S., Levin, J., and Hammar, S. P. 2007. Characteristics of asbestos concentration in lung as compared to asbestos concentration in various levels of lymph nodes that collect drainage from the lung. Ultrastruct. Pathol. 31: 95-133. (Pubitemid 47037176)
51. Dodson, R. F., Williams, M. G., Jr., Corn, C. J., Brollo, A., and Bianchi, C. 1990. Asbestos content of lung tissue, lymph nodes, and pleural plaques from former shipyard workers. Am. Rev. Respir Dis. 142: 843-847. (Pubitemid 20344655)
52. Dodson, R. F., and Ford, J. O. 1985. Early response of the visceral pleura following asbestos exposure: An ultrastructural study. J. Toxicol. Environ. Health 15: 673-686.
53. Dodson, R. F., O'Sullivan, M. F., Huang, J., Holiday, D. B., and Hammar, S. P. 2000. Asbestos in extrapulmonary sites: omentum and mesentery. Chest 117:486-493. (Pubitemid 30111603)
54. Donaldson, K., Borm, P. J., Castranova, V., and Gulumian, M. 2009. The limits of testing particle-mediated oxidative stress in vitro in predicting diverse pathologies; Relevance for testing of nanoparticles. Part. Fibre Toxicol. 6:13.
55. Dostert, C., Pétrilli, V., Van Bruggen, R., Steele, C., Mossman, B. T., and Tschopp, J. 2008. Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science 320:674-677. (Pubitemid 351928351)
56. Dumortier, P., De Vuyst, P., and Rey, F. 1998. Letter to the editor: RE main asbestos type in pleural mesothelioma. Am. J. Ind. Med. 33:94-95.
57. Everitt, J. I., Gelzleichter, T. R., Bermudez, E., Mangum, J. B., Wong, B. A., Janszen, D. B., and Moss, O. R. 1997. Comparison of pleural responses of rats and hamsters to subchronic inhalation of refractory ceramic fibers. Environ. Health Perspect. 105: 1209-1213.
58. Fasske, E. 1986. Pathogenesis of pulmonary fibrosis induced by chrysotile asbestos. Virchows Arch. 408:329-346.
59. Foley-Comer, A. J., Herrick, S. E., Al- Mishlab, T., Prêle, C. M., Laurent, G. J., and Mutsaers, S. E. 2002. Evidence for incorporation of free-floating mesothelial cells as a mechanism of serosal healing. J. Cell. Sci. 115:1383-1389.
60. Fubini, B. 1997. Surface reactivity in the pathogenic response to particulates. Environ. Health Perspect. 105:1013-1020.
61. Fubini, B., and Mollo, L. 1995. Role of iron in the reactivity of mineral fibers. Toxicol. Lett. 82-83:951-960. (Pubitemid 26054775)
62. Gazdar, A. F., Butel, J. S., and Carbone, M. 2002. SV40 and human tumours: myth, association or causality? Nat. Rev. Cancer 2:957-964. (Pubitemid 37328897)
63. Gelzleichter, T. R., Bermudez, E., Mangum, J. B., Wong, B. A., Everitt, J. I., and Moss, O. R. 1996. Pulmonary and pleural responses in Fischer 344 rats following short-term inhalation of a synthetic vitreous fiber. I. Quantitation of lung and pleural fiber burdens. Fundam. Appl. Toxicol. 30:31-38.
64. Gelzleichter, T. R., Bermudez, E., Mangum, J. B., Wong, B. A., Janszen, D. B., Moss, O. R., and Everitt, J. I. 1999. Comparison of pulmonary and pleural responses of rats and hamsters to inhaled refractory ceramic fibers. Toxicol. Sci. 49:93-101. (Pubitemid 29266429)
65. Gelzleichter, T. R., Bermudez, E., Mangum, J. B., Wong, B. A., Moss, O. R., and Everitt, J. I. 1996. Pulmonary and pleural responses in Fischer 344 rats following short-term inhalation of a synthetic vitreous fiber. II. Pathobiologic responses. Fundam. Appl. Toxicol. 30:39-46.
66. Ghio, A. J., Stonehuerner, J. G., Richards, J. H., Crissman, K. M., Roggli, V. L., Piantadosi, C. A., and Carraway, M. S. 2008. Iron homeostasis and oxidative stress in idiopathic pulmonary alveolar proteinosis: A case-control study. Respir Res. 9:10-18.
67. Gibbs, A. R., Stephen, M., Griffith, D. M., Blight, B. J., and Pooley, F. D. 1991. Fibre distribution in the lungs and pleura of subjects with asbestos related diffuse fibrosis. Br. J. Ind. Med. 48:762-770.
68. Greillier, L., Baas, P., Welch, J. J., Hasan, B., and Passioukov, A. 2008. Biomarkers for malignant pleural mesothelioma: current status. Mol. Diagn. Ther. 12:375-390. (Pubitemid 352790451)
69. Greim, H., Borm, P., Schins, R., Donaldson, K., Driscoll, K., Hartwig, A., Kuempel, E., Oberdörster, G., and Speit, G. 2001. Toxicity of fibers and particles. Report of the workshop held in Munich, Germany, 26-27 October 2000. Inhal. Toxicol. 13: 737-754. (Pubitemid 32929239)
70. Hammar, S. P. 1994. The pathology of benign and malignant pleural disease. Chest Surg. Clin. North Am. 4:405-430.
71. Hardy J. A., and Aust, A. E. 1995. The effect of iron binding on the ability of crocidolite asbestos to catalyze DNA single-strand breaks. Carcinogenesis. 16: 319-325.
72. Hei, T. K., Xu, A., Louie, D., and Zhou, Y. L. 2000. Genotoxicity versus carcinogenicity: Implications from fiber toxicity studies. Inhal. Toxicol.12(suppl. 3):141-147.
73. Heintz, N. H., Janssen-Heininger, Y. M., and Mossman, B. T. 2010. Asbestos, lung cancers, and mesotheliomas: from molecular approaches to targeting tumor survival pathways. Am. J. Respir. Cell Mol. Biol. 42: 133-139.
74. Henderson, R. F., Driscoll, K. E., Harkema, J. R., Lindenschmidt, R. C., Chang, I. Y., Maples, K. R., and Barr, E. B. 1995. A comparison of the inflammatory response of the lung to inhaled versus instilled particles in F344 rats. Fundam. Appl. Toxicol. 24: 183-197.
75. Herrick, S. E., and Mutsaers, S. E. 2004. Mesothelial progenitor cells and their potential in tissue engineering. Int. J. Biochem. Cell Biol. 36:621-642.
76. Hill, G. D., Mangum, J. B., Moss, O. R., and Everitt, J. I. 2003. Soluble ICAM-1, MCP-1, and MIP-2 protein secretion by rat pleural mesothelial cells following exposure to amosite asbestos. Exp. Lung Res. 29: 277-290. (Pubitemid 36851254)
77. Hillerdal, G. 1989. Rounded atelectasis. Clinical experience with 74 patients. Chest 95:836-841. (Pubitemid 19102892)
78. Holt, P. F. 1981. Transport of inhaled dust extra-pulmonary sites. J. Pathol. 133:123-129. (Pubitemid 11174747)
79. Huang, S. X. L., Jaurand, M. C., Kamp, D. W., Whysner, J., and Hei, T. K. 2011. Role of mutagenicity in mineral fiber-induced carcinogenicity and other diseases. J. Toxicol. Environ. Health B, 14:179-245.
80. Husain, A. N., Colby, T. V., Ordonez, N. G., Krausz, T., Borczuk, A., Cagle, P. T., Chirieac, L. R., Chur, A., Galateau-Salle, F., Gibbs, A. R., Gown, A. M., Hammar, S. P., Litzky, L. A., Roggli, V. L., Travis, W. D., and Wick, M. R. 2009. Guidelines for pathologic diagnosis of malignant mesothelioma: A consensus statement from the International Mesothelioma Interest Group. Arch. Pathol. Lab. Med. 133:1317-1331.
81. Institute of Medicine. 2006. Asbestos: Selected cancers. Washington, DC: National Academies Press.
82. International Life Sciences Institute. 2005. Testing of fibrous particles: Short-term assays and strategies. Report of an ILSI Risk Science Institute Working Group. Inhal. Toxicol. 17:497-537.
83. Janssen-Heininger, Y. M., Mossman, B. T., Heintz, N. H., Forman, H. J., Kalyanaraman, B., Finkel, T., Stamler, J. S., Rhee, S. G., and van der Vliet, A. 2008. Redox-based regulation of signal transduction: principles, pitfalls, and promises. Free Radical Biol. Med. 45:1-17.
84. Jantz, M. A., and Antony, V. B. 2008. Pathophysiology of the pleura. Respiration 75:121-133.
85. Jarabek, A. M., Asgharian, B., and Miller, F. J. 2005. Dosimetric adjustments for interspecies extrapolation of inhaled poorly soluble particles (PSP). Inhal.Toxicol. 17: 317-334. (Pubitemid 40909581)
86. Jaurand, M. C. 1996. Use of in-vitro genotoxicity and cell transformation assays to evaluate the potential carcinogenicity of fibres. IARC Sci. Publ. 140:55-72.
87. Jaurand, M. C., Renier, A., and Daubriac, J. 2009. Mesothelioma: Do asbestos and carbon nanotubes pose the same health risk? Part. Fibre Toxicol. 6:16-30.
88. 2. Am. J. Physiol. 273:L1029-L1035.
89. Kean, J. M., Rao, S., Wang, M., and Garcea, R. L. 2009. Seroepidemiology of human polyomaviruses. PLoS Pathol. doi: 10.1371/journal.ppat.1000363.
90. Kishomoto, T., Ono, T., Okada, K., and Ito, H. 1989. Relationship between number of asbestos bodies in autopsy lung and pleural plaques on chest X-ray film. Chest 95: 549-552. (Pubitemid 19094442)
91. Kratzke, R. A., and Gazdar, A. F. 2005. Oncogenes and tumur suppressor genes in malignant mesothelioma. In Advances in pathogenesis, diagnosis, and translational therapies, vol. 8, eds. H. I. Pass, N. J. Vogelzang, and M. Carbone, pp. 124-140. New York: Springer Science & Business Media.
92. Kroczynska, B., Cutrone, R., Bocchetta, M., Yang, H., Elmishad, A. G., Vacek, P., Ramos-Nino, M., Mossman, B. T., Pass, H. I., and Carbone, M. 2006. Crocidolite asbestos and SV40 are cocarcinogens in human mesothelial cells and in causing mesothelioma in hamsters. Proc. Natl. Acad. Sci. USA 103:14128-4133. (Pubitemid 44452991)
93. Lee, M. M., Green, F. H., Demetrick, D. J., Jiang, X. X., and Schürch, S. 1993. A study of surface property changes in rat mesothelial cells induced by asbestos using aqueous two-phase polymer solutions. Biochim. Biophys. Acta.1181:223-232. (Pubitemid 23177212)
94. Lehnert, B. E., Valdez, Y. E., and Bomalaski, S. H. 1985. Lung and pleural free-cell responses to the intrapulmonary deposition of particles in the rat. J. Toxicol. Environ. Health 16:823-839.
95. Light, R. W., and Broaddus, V. C. 2010. Pleural Effusion and Pleural Tumors. In Murray and Nadel's Textbook of Respiratory Medicine, 5th ed. Eds. J. R. Mason, V. C. Broaddus, T. R. Martin, T. E. King, Jr., D. E. Schraufnagel, J. F. Murray, and J. A. Nadel. pp. 1719-1763, 1792-1813, vol. 2. Philadelphia, Elsevier Saunders.
96. Lillis, R., Lerman, Y., and Selikoff, I. J. 1988. Symptomatic benign pleural effusions among asbestos insulation workers: Residual radiographic abnormalities. Br. J. Ind. Med. 45:443-449.
97. Lippmann, M., and Schlesinger, R. B. 1984. Interspecies comparisons of particle deposition and mucociliary clearance in tracheobronchial airways. J. Toxicol. Environ. Health. 13:441-469.
98. Lippmann, M., Yeates, D. B., and Albert, R. E. 1980. Deposition, retention, and clearance of inhaled particles. Br. J. Ind. Med. 37: 337-362.
99. Liu, W., Ernest, J. D., and Broaddus, V. C. 2000. Phagocytosis of crocidolite asbestos induces oxidative stress, DNA damage and apoptosis in mesothelial cells. Am. J. Respir. Cell Mol. Biol. 23:371-378.
100. Lockey, J. E., Brooks, S. M., Jarabek, A. M., Khoury, P. R., McKay, R. T., Carson, A., Morrison, J. A., Wiot, J. F., and Spitz, H. B. 1984. Pulmonary changes after exposure to vermiculite contaminated with fibrous tremolite. Am. Rev. Respir. Dis. 129: 952-958.
101. Manning, C. B., Vallyathan, V., and Mossman, B. T. 2002. Diseases caused by asbestos: mechanisms of injury and disease development. Int. Immunopharmacol. 2:191-200.
102. Marchi, E., Liu, W., and Broaddus, V. C. 2000. Mesothelial cell apoptosis is confirmed in vivo by morphological change in cytokeratin distribution. Am. J. Physiol. Lung Cell. Mol. Physiol. 278:L528-L535.
103. Mast, R. W., Hesterberg, T. W., Glass, L. R., McConnell, E. E., Anderson, R., and Bernstein, D. M. 1994. Chronic inhalation and biopersistence of refractory ceramic fiber in rats and hamsters. Environ. Health Perspect. 102:207-209.
104. Maxim, L. D., and McConnell, E. E. 2001. Interspecies comparisons of the toxicity of asbestos and synthetic vitreous fibers: A weight-of-the-evidence approach. Regul. Toxicol. Pharmacol. 33:319-342.
105. Meeker, G., Bern, A. M., Brownfield, I. K., Lowers, H. A., Sutley, S. J., Hoefen, T. M., and Vance, J. S. 2003. The composition and morphology of amphiboles from the Rainy Creek complex, near Libby, Montana. Am. Mineral. 88:1955-1969. (Pubitemid 38098172)
106. McConnell, E. E. 1994. Synthetic vitreous fibers - Inhalation studies. Regul. Toxicol. Pharmacol. 20:S22-S34.
107. McConnell, E. E., Axten, C., Hesterberg, T. W., Chevalier, J., Miller, W. C., Everitt, J., Oberdörster, G., Chase, G. R., Thevenaz, P., and Kotin, P. 1999. Studies on the inhalation toxicology of two fiberglasses and amosite asbestos in the Syrian golden hamster. Part II. Results of chronic exposure. Inhal. Toxicol. 11:785-835. (Pubitemid 29456281)
108. McDonald, J. C., Armstrong, B. G., Edwards, C. W., Gibbs, A. R., Lloyd, H. M., Pooley, F. D., Ross, D. J., and Rudd, R. M. 2001. Case-referent survey of young adults with mesothelioma: I. Lung fibre analyses. Ann. Occup. Hyg. 45:513-518.
109. Miserocchi, G., Sancini, G., Mantegazza, F., and Chiappino, G. 2008. Translocation pathways for inhaled asbestos fibers. Environ. Health 7:4.
110. Mitchev, K., Dumortier, P., and De Vuyst, P. 2002. Black spots and hyaline pleural plaques on the parietal pleura of 150 urban necropsy cases. Am. J. Surg. Pathol. 26:1198-1206. (Pubitemid 34969189)
111. Mossman, B. T., Lippman, M., Hesterberg, T. W., Kelsey, K. T., Barchowsky, A., and Bonner, J. C. 2011. Pulmonary endpoints (lung carcinomas and asbestosis) following inhalation exposure to asbestos. J. Toxicol. Environ. Health B, 14: 76-121.
112. Murthy, S. S., and Testa, J. R. 1999. Asbestos, chromosomal deletions, and tumor suppressor gene alterations in human malignant mesothelioma. J. Cell Physiol. 180: 150-157.
113. Mutsaers, S. E., Kalomenidis, I., Wilson, N. A., and Lee, Y. C. 2006. Growth factors in pleural fibrosis. Curr. Opin. Pulm. Med. 12: 251-258.
114. Mutsaers, S. E., Prele, C. M., Brody, A. R., and Idell, S. 2004. Pathogenesis of pleural fibrosis. Respirology 9:428-440. (Pubitemid 40179747)
115. Nishimura, S. L., and Broaddus, V. C. 1998. Asbestos-induced pleural disease. Clin. Chest Med. 19:311-329.
116. Oberdörster, G., Ferin, J., Marcello, N. L., and Meinhold, S. H. 1983. Effects of intrabronchially instilled amosite on lavagable lung and pleural cells. Environ Health Perspect. 51:41-48.
117. Oberdörster, G. 2000. Determinants of the pathogenicity of man-made vitreous fibers (MMVF). Int. Arch. Occup. Environ. Health 73:S60-S68. (Pubitemid 30487398)
118. Oberdörster, G. 2002. Toxicokinetics and effects of fibrous and nonfibrous particles. Inhal. Toxicol. 14:29-56. (Pubitemid 34094359)
119. Owens, M. W., and Milligan, S. A. 1995. Pleuritis abd pleural effusions. Curr. Opin. Pulm. Med. 1:318-323.
120. Pache, J. C., Janssen, Y. M., Walsh, E. S., Quinlan, T. R., Zanella, C. L., Low, R. B., Taatjes, D. J., and Mossman, B. T. 1998. Increased epidermal growth factor-receptor protein in a human mesothelial cell line in response to long asbestos fibers. Am. J. Pathol. 152:333-340.
121. Peipins, L. A., Lewin, M., Campolucci, S., Lybarger, J. A., Miller, A., Middleton, D., Weis, C., Spence, M., Black, B., and Kapil, V. 2003. Radiographic abnormalities and exposure to asbestos-contaminated vermiculite in the community of Libby, Montana, USA. Environ. Health Perspect. 111:1753-1759.
122. Poland, C. A., Duffin, R., Kinloch, I., Maynard, A., Wallace, W. A., Seaton, A., Stone, V., Brown, S., Macnee, W., and Donaldson, K. 2008. Carbon nanotubes introduced into the abdominal cavity of mice show asbestos-like pathogenicity in a pilot study. Nat. Nanotechnol. 3:423-428.
123. Pott, F. 1980. Animal experiments on biological effects of mineral fibres. IARC Sci. Publ. 30:261-272.
124. Pott, F., Huth, F., and Friedrichs, K. H. 1974. Tumorigenic effect of fibrous dusts in experimental animals. Environ. Health Perspect. 9:313-315.
125. Robledo, R., and Mossman, B. 1999. Cellular and molecular mechanisms of asbestosinduced fibrosis. J. Cell Physiol. 180: 158-166. (Pubitemid 29297192)
126. Roggli, V. L., Sharma, A., Butnor, K. J., Sporn, T., and Vollmer, R. T. 2002. Malignant mesothelioma and occupational exposure to asbestos: A clinicopathological correlation of 1445 cases. Ultrastruct. Pathol. 26:55-65.
127. Roggli, V. L. 1990. Human disease consequences of fiber exposures: A review of human pathology and fiber burden data. Environ. Health Perspect. 88:295-303.
128. Roggli, V. L. 1992. Quantitative and analytical studies in the diagnosis of mesotheliomas. Sem. Diag. Pathol. 9:162-168.
129. Roggli, V. L., and Sanders, L. L. 2000. Asbestos content of lung tissue and carcinoma of the lung: A clinicopathologic correlation and mineral fiber analysis of 234 cases. Ann. Occup. Hyg. 44:109-117.
130. Roggli, V. L., and Sharma, A. 2004. Analysis of tissue mineral fiber content In Pathology of asbestos-associated disease, 2nd ed., eds. V. L. Roggl, T. D. Oury, and T. A. Spron, pp. 309-354. New York: Springer-Verlag.
131. Rohs, A. M., Lockey, J. E., Dunning, K. K., Shukla, R., Fan, H., Hilbert, T., Borton, E., Wiot, J., Meyer, C., Shipley, R. T., Lemasters, G. K., and Kapil, V. 2008. Low-level fiber-induced radiographic changes caused by Libby vermiculite: A 25-year follow-up study. Am. J. Respir. Crit. Care Med. 177:630-637.
132. Ryman-Rasmussen, J. P., Cesta, M. F., Brody, A. R., Shipley-Phillips, J. K., Everitt, J. I., Tewksbury, E. W., Moss, O. R., Wong, B. A., Dodd, D. E., Andersen, M. E., and Bonner, J. C. 2009. Inhaled carbon nanotubes reach the subpleural tissue in mice. Nat. Nanotechnol. 4:747-751.
133. Sahn, S. A., and Antony, V. B. 1984. Pathogenesis of pleural plaques. Relationship of early cellular response and pathology. Am. Rev. Respir. Dis. 130:884-887.
134. Sanchez, V. C., Pietruska, J. R., Miselis, N. R., Hurt, R. H., and Kane, A. B. 2009. Biopersistence and potential adverse health impacts of fibrous nanomaterials:What have we learned from asbestos? Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 1: 511-529.
135. Sebastien, P., Janson, X., Gaudichet, A., Hirsch, A., and Bignon, J. 1980. Asbestos retention in human respiratory tissues: Comparative measurements in lung parenchyma and in partial pleura. IARC Sci. Publ. 30:237-246.
136. Shukla, A., Gulumian, M., Hei, T. K., Kamp, D., Rahman, Q., and Mossman, B. T. 2003. Multiple roles of oxidants in the pathogenesis of asbestos-induced diseases. Free Radical Biol. Med. 34:1117-1129.
137. Shukla, A., Jung, M., Stern, M., Fukagawa, N. K., Taatjes, D. J., Sawyer, D., Van Houten, B., and Mossman, B. T. 2003. Asbestos induces mitochondrial DNA damage and dysfunction linked to the development of apoptosis. Am. J. Physiol. Lung Cell. Mol. Physiol. 285:L1018-L1025.
138. Stanton, M. F., Blackwell, R., and Miller, E. 1969. Experimental pulmonary carcinogenesis with asbestos. Am. Ind. Hyg. Assoc. J. 30:236-244.
139. Stanton, M. F., Layard, M., Tegeris, A., Miller, E., May, M., Morgan, E., and Smith, A. 1981. Relation of particle dimension to carcinogenicity in amphibole asbestoses and other fibrous minerals. JNCI 67:965-975. (Pubitemid 12252082)
140. Stanton, M. F., Laynard, M., Tegeris, A., Miller, E., May, M., and Kent, E. 1977. Carcinogenicity of fibrous glass: Pleural response in the rat in relation to fiber dimension. J. Natl. Cancer Inst. 58: 587-603. (Pubitemid 8056557)
141. Stephens, M., Gibbs, A. R., Pooley, F. D, and Wagner, J. C. 1987. Asbestos induced diffuse pleural fibrosis: pathology and mineralogy. Thorax 42:583-588.
142. Sullivan, P. A. 2007. Vermiculite, respiratory disease, and asbestos exposure in Libby, Montana: update of a cohort mortality study. Environ Health Perspect. 115: 579-585. (Pubitemid 46585530)
143. Suzuki, Y., and Kohyama, N. 1991. Translocation of inhaled asbestos fibers from the lung to other tissues. Am. J. Ind. Med. 19:701-704.
144. Suzuki, Y., Yuen, S. R., and Ashley, R. 2005. Short, thin asbestos fibers contribute to the development of human malignant mesothelioma: Pathological evidence. Int. J. Hyg. Environ. Health 208:201-210. (Pubitemid 40592093)
145. Suzuki, Y., and Yuen, S. R. 2001. Asbestos tissue burden study on human malignant mesothelioma. Ind. Health 39: 150-160.
146. Suzuki, Y., Yuen, S. R., and Ashley, R. 2005. Short, thin asbestos fibers contribute to the development of human malignant mesothelioma: Pathological evidence. Int. J. Hyg. Environ. Health 208:201-210. (Pubitemid 40592093)
147. Tanaka, S., Choe, N., Iwagaki, A., Hemenway, D. R., and Kagan, E. 2000. Asbestos exposure induces MCP-1 secretion by pleural mesothelial cells. Exp. Lung Res. 26: 241-255. (Pubitemid 30418775)
148. Tyler, W. S. 1983. Comparative subgross anatomy of lungs. Pleurae, interlobular septa, and distal airways. Am. Rev. Respir. Dis. 128:S32-S36. (Pubitemid 13039288)
149. Upadhyay, D., and Kamp, D. W. 2003. Asbestos-induced pulmonary toxicity: role of DNA damage and apoptosis. Exp. Biol. Med. 228:650-659.
150. Viallat, J. R., Raybuad, F., Passarel, M., and Boutin, C. 1986. Pleural migration of chrysotile fibers after intratracheal injection in rats. Arch. Environ. Health 41:282-286. (Pubitemid 17001855)
151. Wang, N. S. 1975. The preformed stomas connecting the pleural cavity and the lymphatics in the parietal pleura. Am. Rev. Respir. 110:623-633.
152. Weiner, S. J., and Neragi-Miandoab, S. 2009. Pathogenesis of malignant pleural mesothelioma and the role of environmental and genetic factors. J. Cancer Res. Clin. Oncol. 135:15-27.
153. Whitehouse, A. C. 2004. Asbestos-related pleural disease due to tremolite associated with progressive loss of lung function: Serial observations in 123 miners, family members, and residents of Libby, Montana. Am. J. Ind. Med. 46: 219-225. (Pubitemid 39180817)
154. Yang, H., Bocchetta, M., Kroczynska, B., Elmishad, A. G., Chen, Y., Liu, Z., Bubici, C., Mossman, B. T., Pass, H. I., Testa, J. R., Franzoso, G., and Carbone, M. 2006. TNF-alpha inhibits asbestos-induced cytotoxicity via a NF-kappaB-dependent pathway, a possible mechanism for asbestos-induced oncogenesis. Proc. Natl. Acad. Sci. USA 103:10397-10402. (Pubitemid 44051178)
155. Yang, H., Rivera, Z., Jube, S., Nasu, M., Bertino, P., Goparaju, C., Franzoso, G., Lotze, M. T., Krausz, T., Pass, H. I., Bianchi, M. E., and Carbone, M. 2010. Programmed necrosis induced by asbestos in human mesothelial cells causes high-mobility group box 1 protein release and resultant inflammation. Proc. Natl. Acad. Sci. USA 107: 12611-12616.